Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LPG
|
Thomas Jason Coleman
Director |
SELL
Open market or private sale
|
Indirect | 50,000 Reduced 1.43% |
$740,500
$14.81 p/Share
|
Apr 01
2022 |
|
CHRS
|
Vladimir Vexler
Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,458 Reduced 3.22% |
$44,435
$12.85 p/Share
|
Apr 01
2022 |
|
CHRS
|
Mc David Stilwell
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,458 Reduced 4.73% |
$44,435
$12.85 p/Share
|
Apr 01
2022 |
|
CHS
|
Joseph R. Topper Jr.
EVP - Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,059 Reduced 3.35% |
$19,605
$4.83 p/Share
|
Apr 01
2022 |
|
QTRX
|
Dawn Mattoon
Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct | 261 Reduced 0.7% |
$7,775
$29.79 p/Share
|
Apr 01
2022 |
|
QTRX
|
John J Fry
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 524 Reduced 1.7% |
$15,610
$29.79 p/Share
|
Apr 01
2022 |
|
QTRX
|
Mark T. Roskey
SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct | 171 Reduced 0.76% |
$5,094
$29.79 p/Share
|
Apr 01
2022 |
|
QTRX
|
E Kevin Hrusovsky
Executive Chairman |
SELL
Open market or private sale
|
Direct | 868 Reduced 0.1% |
$25,858
$29.79 p/Share
|
Apr 01
2022 |
|
QTRX
|
Paul M Meister |
BUY
Grant, award, or other acquisition
|
Direct | 492 Added 2.75% |
$14,991
$30.47 p/Share
|
Apr 01
2022 |
|
QTRX
|
Sarah E. Hlavinka |
BUY
Grant, award, or other acquisition
|
Direct | 451 Added 2.86% |
$13,742
$30.47 p/Share
|
Apr 01
2022 |
|
QTRX
|
Keith Crandell |
BUY
Grant, award, or other acquisition
|
Direct | 492 Added 0.41% |
$14,991
$30.47 p/Share
|
Apr 01
2022 |
|
SLRC
|
David Wachter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7,102 Added 11.72% |
-
|
Apr 01
2022 |
|
SLRC
|
Leonard Potter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,872 Added 24.68% |
-
|
Apr 01
2022 |
|
SLRC
|
Steven Hochberg
Director |
BUY
Grant, award, or other acquisition
|
Direct | 15,592 Added 37.86% |
-
|
Apr 01
2022 |
|
SLRC
|
Richard Peteka
CFO, SEC, TREAS |
BUY
Grant, award, or other acquisition
|
Direct | 4,872 Added 14.44% |
-
|
Apr 01
2022 |
|
SLRC
|
Bruce J Spohler |
BUY
Grant, award, or other acquisition
|
Direct | 5,847 Added 7.15% |
-
|
Apr 01
2022 |
|
SLRC
|
Bruce J Spohler |
BUY
Grant, award, or other acquisition
|
Indirect | 603,541 Added 16.23% |
-
|
Apr 01
2022 |
|
SLRC
|
Michael S Gross |
BUY
Grant, award, or other acquisition
|
Direct | 225,180 Added 32.5% |
-
|
Apr 01
2022 |
|
SLRC
|
Michael S Gross |
BUY
Grant, award, or other acquisition
|
Indirect | 480,448 Added 14.03% |
-
|
Apr 01
2022 |
|
ORGO
|
Patrick Bilbo
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,497 Reduced 1.34% |
$19,701
$7.89 p/Share
|
Apr 01
2022 |
|
ORGO
|
Lori Freedman
Chief Admin. and Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,984 Reduced 3.99% |
$23,544
$7.89 p/Share
|
Apr 01
2022 |
|
ORGO
|
Antonio S. Montecalvo
Vice President, Health Policy |
SELL
Payment of exercise price or tax liability
|
Direct | 2,738 Reduced 6.18% |
$21,603
$7.89 p/Share
|
Apr 01
2022 |
|
ORGO
|
Gary S. Gillheeney
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 9,789 Reduced 2.4% |
$77,235
$7.89 p/Share
|
Apr 01
2022 |
|
ORGO
|
Brian Grow
Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,977 Reduced 2.22% |
$15,599
$7.89 p/Share
|
Apr 01
2022 |
|
KROS
|
Christopher Rovaldi
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 864 Reduced 100.0% |
$49,118
$56.85 p/Share
|
Apr 01
2022 |
|
KROS
|
Christopher Rovaldi
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 864 Added 50.0% |
$13,824
$16.0 p/Share
|
Apr 01
2022 |
|
CRMT
|
Joshua G Welch
Director |
SELL
Other acquisition or disposition
|
Indirect | 1,500 Reduced 1.18% |
$120,840
$80.56 p/Share
|
Apr 01
2022 |
|
CDLX
|
Andrew Christiansen
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,678 Added 28.91% |
-
|
Apr 01
2022 |
|
CDLX
|
Scott D. Grimes
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 14,920 Added 6.08% |
-
|
Apr 01
2022 |
|
CDLX
|
Lynne Marie Laube
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,161 Added 5.36% |
-
|
Apr 01
2022 |
|
CDLX
|
Kirk Somers
Chief Legal & Privacy Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 8,468 Added 16.01% |
-
|
Apr 01
2022 |
|
ABTX
|
Vitulli, Iii Ramon A.
President |
SELL
Payment of exercise price or tax liability
|
Direct | 346 Reduced 0.95% |
$15,169
$43.84 p/Share
|
Apr 01
2022 |
|
ABTX
|
Shanna R. Kuzdzal
EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 133 Reduced 0.83% |
$5,831
$43.84 p/Share
|
Apr 01
2022 |
|
ABTX
|
Steven F. Retzloff
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 263 Reduced 0.77% |
$11,530
$43.84 p/Share
|
Apr 01
2022 |
|
ABTX
|
Paul P Egge
Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 168 Reduced 1.01% |
$7,365
$43.84 p/Share
|
Apr 01
2022 |
|
POSH
|
Manish Chandra
President and CEO |
BUY
Conversion of derivative security
|
Direct | 2,109 Added 18.31% |
-
|
Apr 01
2022 |
|
POSH
|
John Michael Mc Donald
Chief Operating Officer |
BUY
Conversion of derivative security
|
Direct | 3,162 Added 3.42% |
-
|
Apr 01
2022 |
|
UIS
|
Philippe Germond
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 780 Reduced 1.11% |
$16,669
$21.37 p/Share
|
Apr 01
2022 |
|
ZETA
|
William Landman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,960 Added 50.0% |
$24,990
$12.75 p/Share
|
Apr 01
2022 |
|
PRDO
|
Elise Baskel
SVP, CTU |
SELL
Open market or private sale
|
Direct | 9,508 Reduced 10.8% |
$109,627
$11.53 p/Share
|
Apr 01
2022 |
|
QCRH
|
John F Griesemer
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 75,588 Added 50.0% |
$4,252,581
$56.26 p/Share
|
Apr 01
2022 |
|
QCRH
|
John F Griesemer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,599 Added 50.0% |
$89,960
$56.26 p/Share
|
Apr 01
2022 |
|
REPL
|
Colin Love
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 26,250 Added 3.29% |
-
|
Apr 01
2022 |
|
REPL
|
Pamela Esposito
Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct | 22,750 Added 8.9% |
-
|
Apr 01
2022 |
|
REPL
|
Tanya Lewis
Chief Dev. Op. Officer |
BUY
Grant, award, or other acquisition
|
Direct | 52,500 Added 29.44% |
-
|
Apr 01
2022 |
|
REPL
|
Sushil Patel
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 52,500 Added 27.16% |
-
|
Apr 01
2022 |
|
REPL
|
Jean M. Franchi
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 52,500 Added 34.76% |
-
|
Apr 01
2022 |
|
REPL
|
Robert Coffin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 26,250 Added 1.44% |
-
|
Apr 01
2022 |
|
REPL
|
Philip Astley Sparke
Director |
BUY
Grant, award, or other acquisition
|
Direct | 70,000 Added 4.73% |
-
|
Apr 01
2022 |
|
TDW
|
Larry T Rigdon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,101 Added 1.38% |
$24,442
$22.2 p/Share
|
Apr 01
2022 |